Biotech News - Page 9

Biotech News Feed

CHIRAL CHEMICALS - An Exclusive Market Insight Report Update
May 7, 2012
It is important for a chiral drug to be present in a pure therapeutically active form so as to avoid the possibility of any untoward effects.
RNAi - A Breakthrough in Molecular Biology - An Exclusive Market Insight Report Update
May 5, 2012
The dedicated team works 24/7 to deliver unique reports that are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools.
HIGH THROUGHPUT SCREENING - An Exclusive Market Insight Report Update
May 5, 2012
RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis.
ADME TOX TECHNOLOGIES - An Exclusive Market Insight Report Update
May 4, 2012
ADME/Tox Technologies gives a market insight into products and services used in the ADME/Tox industry. Predictive technologies analyzed include In vivo, In vitro, and In silico.
Saudi Arabia's e-Health Thriving Unprecedentedly
April 26, 2012
Saudi Arabian healthcare sector is anticipated to expand at a CAGR of around 7% during 2012-2015, says RNCOS in its latest research report.
Satisfactory Performance to Originate from Global Contract Manufacturing Market
April 24, 2012
Backed by strong investment, the Chinese contract manufacturing industry is anticipated to attract substantial revenue patterns in future, says RNCOS.
Telemedicine in US Flourishing through Funding Grants
April 20, 2012
Aided by several funding grants and prevalent conditions, the global telemedicine market is estimated to grow at a CAGR of around 19% during 2010-2015, says RNCOS.
RNAi Therapeutics Exhibits Untapped Potential in Global RNAi Market
April 16, 2012
RNAi therapeutics is the upcoming future and is expected to unfold untapped future in the global RNAi market, says RNCOS.
Allovectin-7 to Enlarge Gene Therapy Revenue Patterns
April 16, 2012
Allovectin-7 (velimogene aliplasmid) is anticipated to generate estimated revenue worth US$ 400 Million in the US after its projected launch in 2012-2013, says RNCOS.
Bathroom Vanities Ideas for Little Moving Bathrooms
April 16, 2012
Everyone wants to have a Bathroom Vanities that is both efficient and fashionable as well.
View Page: 1 2 3 4 5 6 7 8 [9] 10 11 12 13 14 15